These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 12207762)

  • 1. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS).
    Schallreuter KU; Moore J; Behrens-Williams S; Panske A; Harari M
    Int J Dermatol; 2002 Aug; 41(8):482-7. PubMed ID: 12207762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.
    Schallreuter KU; Krüger C; Würfel BA; Panske A; Wood JM
    Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic evidence for epidermal H2O2/ONOO(-)-mediated oxidation/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS.
    Schallreuter KU; Salem MA; Holtz S; Panske A
    FASEB J; 2013 Aug; 27(8):3113-22. PubMed ID: 23629861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.
    Bakis-Petsoglou S; Le Guay JL; Wittal R
    Br J Dermatol; 2009 Oct; 161(4):910-7. PubMed ID: 19523170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase.
    Schallreuter KU; Moore J; Wood JM; Beazley WD; Gaze DC; Tobin DJ; Marshall HS; Panske A; Panzig E; Hibberts NA
    J Investig Dermatol Symp Proc; 1999 Sep; 4(1):91-6. PubMed ID: 10537016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dead Sea climatotherapy for vitiligo: a retrospective study of 436 patients.
    Czarnowicki T; Harari M; Ruzicka T; Ingber A
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):959-63. PubMed ID: 21129041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of oxidative stress in vitiligo.
    Schallreuter KU
    Skin Pharmacol Appl Skin Physiol; 1999; 12(3):132-8. PubMed ID: 10393521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogens can contribute to hydrogen peroxide generation and quinone-mediated DNA damage in peripheral blood lymphocytes from patients with vitiligo.
    Schallreuter KU; Chiuchiarelli G; Cemeli E; Elwary SM; Gillbro JM; Spencer JD; Rokos H; Panske A; Chavan B; Wood JM; Anderson D
    J Invest Dermatol; 2006 May; 126(5):1036-42. PubMed ID: 16528352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients.
    Schallreuter KU; Wood JM; Lemke KR; Levenig C
    Dermatology; 1995; 190(3):223-9. PubMed ID: 7599386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen peroxide regulates the cholinergic signal in a concentration dependent manner.
    Schallreuter KU; Elwary S
    Life Sci; 2007 May; 80(24-25):2221-6. PubMed ID: 17335854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
    Asawanonda P; Klahan SO
    Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
    Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic research confirms coexistence of acquired Blaschkolinear Vitiligo and acrofacial Vitiligo.
    Schallreuter KU; Krüger C; Rokos H; Hasse S; Zothner C; Panske A
    Arch Dermatol Res; 2007 Aug; 299(5-6):225-30. PubMed ID: 17404749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo.
    Spencer JD; Gibbons NC; Rokos H; Peters EM; Wood JM; Schallreuter KU
    J Invest Dermatol; 2007 Feb; 127(2):411-20. PubMed ID: 16946714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of vitiligo with narrow-band UVB and topical gel containing catalase and superoxide dismutase.
    Kostović K; Pastar Z; Pasić A; Ceović R
    Acta Dermatovenerol Croat; 2007; 15(1):10-4. PubMed ID: 17433173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel topical cream delivers safe and effective sunlight therapy for vitiligo by selectively filtering damaging ultraviolet radiation.
    Goren A; Salafia A; McCoy J; Keene S; Lotti T
    Dermatol Ther; 2014; 27(4):195-7. PubMed ID: 24548413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations.
    Bayoumi W; Fontas E; Sillard L; Le Duff F; Ortonne JP; Bahadoran P; Lacour JP; Passeron T
    Br J Dermatol; 2012 Jan; 166(1):208-11. PubMed ID: 21824124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment and combination approaches for vitiligo: new insights, new developments.
    Hossani-Madani AR; Halder RM
    G Ital Dermatol Venereol; 2010 Feb; 145(1):57-78. PubMed ID: 20197746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perturbed 6-tetrahydrobiopterin recycling via decreased dihydropteridine reductase in vitiligo: more evidence for H2O2 stress.
    Hasse S; Gibbons NC; Rokos H; Marles LK; Schallreuter KU
    J Invest Dermatol; 2004 Feb; 122(2):307-13. PubMed ID: 15009710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
    Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
    Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.